{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreig4a4sznpkxkfesmpvbh76nwneekl2lyzw4e2kcqdylhrec6rke3y",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mmi5mk5iooo2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreibrmrrsdqbkf4epu7noslvam3yyyzxw7nex7wd4psdsydg6stch5y"
    },
    "mimeType": "image/jpeg",
    "size": 573417
  },
  "path": "/news/2026-05-treatment-rare-brain-spinal-cord.html",
  "publishedAt": "2026-05-22T19:40:02.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "A new study has identified hepatitis A virus cellular receptor 1 (HAVCR1) as a biomarker that could make it easier to diagnose rare but aggressive forms of brain and eye cancer earlier and with fewer invasive tests.",
  "title": "New study could improve testing and treatment for rare brain, spinal cord, and eye cancers"
}